Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01928420 · ClinicalTrials.gov registry record · Phase 2
A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease
A Phase 2 study, sponsored by Humanetics Corporation.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT01928420 is a Phase 2 study that has completed, run by Humanetics Corporation. The registered enrollment target is 30 participants.
The verdict
NCT01928420, a Phase 2 study, has completed, sponsored by Humanetics Corporation.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of NIC5-15 in the treatment of Alzheimer's Disease.
Interventions
- DRUG Placebo
- DRUG Drug: NIC5-15
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2007-04 |
| Est. Completion | 2014-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01928420
The ClinicalTrials.gov registry entry for NCT01928420 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Humanetics Corporation, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01928420 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01928420 about?
NCT01928420 is a clinical study titled "A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease". The purpose of this study is to evaluate the safety and efficacy of NIC5-15 in the treatment of Alzheimer's Disease.
What is the current status of trial NCT01928420?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2007-04. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01928420?
The interventions under investigation include: Placebo (DRUG), Drug: NIC5-15 (DRUG).
Who is sponsoring clinical trial NCT01928420?
This trial is sponsored by Humanetics Corporation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.